Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
NCT ID: NCT04915911
Last Updated: 2021-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-07-01
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
NCT04933214
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027
Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease
NCT02942511
Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease
NCT05815355
Microflora and Metabolomics of Crohn's Disease Patients
NCT04965584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adult patients with Crohn's disease
multi-center cross-sectional study
cross-sectional study
cross-sectional study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cross-sectional study
cross-sectional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of CD;
* Admission time \<48 hours;
* Subject has voluntarily signed and dated an informed consent form.
Exclusion Criteria
* Unstable vital signs or unstable hemodynamics;
* Pregnant or lactating women;
* Admission to hospital due to other critical illnesses (such as tumor, HIV, severe infections requiring ventilator or CRRT treatment);
* Dying patients whose life expectancy does not exceed 24 hours;
* Severe liver insufficiency (liver function score 11-15 or total bilirubin\> 3mg/dL or tissue biopsy diagnosed as liver cirrhosis, hepatic encephalopathy, portal hypertension with history of gastrointestinal hemorrhage, etc.);
* Severe renal insufficiency (creatinine value is 2 times higher than the upper limit of normal);
* Severe metabolic diseases (such as metabolic syndrome, hyperthyroidism, etc.);
* Patients whose burn area exceeds 20% of the body surface area;
* Immunodeficiency, autoimmune disease, or receiving immunosuppressive treatment for diseases other than CD (such as organ transplantation, etc.);
* Those who are not suitable for body composition analysis
* Patients who have been selected for other clinical studies or have been selected for this study;
* Subjects are unwilling to participate in this study or refuse to sign informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.